TrialRMD open2021

Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE).

Daniel Aletaha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.